Get the Stockscreener App
7.98
3.62%
-0.30
After Hours:
7.96
-0.02
-0.25%
Novavax Inc stock is traded at $7.98, with a volume of 7.15M.
It is down -3.62% in the last 24 hours and down -5.90% over the past month.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
See More
Previous Close:
$8.28
Open:
$8.21
24h Volume:
7.15M
Relative Volume:
1.15
Market Cap:
$1.30B
Revenue:
$1.08B
Net Income/Loss:
$422.82M
P/E Ratio:
3.50
EPS:
2.28
Net Cash Flow:
$-637.33M
1W Performance:
+1.01%
1M Performance:
-5.90%
6M Performance:
-1.48%
1Y Performance:
-33.05%
1-Day Range:
$7.83
$8.29
1-Week Range:
$7.63
$8.31
52-Week Range:
$5.01
$15.22
Novavax Inc Stock (NVAX) Company Profile
Name
Novavax Inc
Sector
Industry
Phone
240-268-2000
Address
700 QUINCE ORCHARD ROAD, GAITHERSBURG, MD
Compare NVAX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NVAX
Novavax Inc
|
7.98 | 1.29B | 1.08B | 422.82M | -637.33M | 2.28 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Novavax Inc Stock (NVAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-28-25 | Resumed | H.C. Wainwright | Buy |
| Aug-20-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Jun-17-25 | Initiated | Citigroup | Sell |
| Feb-28-25 | Initiated | BTIG Research | Buy |
| Jul-30-24 | Downgrade | JP Morgan | Neutral → Underweight |
| May-10-24 | Upgrade | BofA Securities | Underperform → Neutral |
| May-10-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Aug-09-23 | Upgrade | B. Riley Securities | Neutral → Buy |
| Apr-20-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| Mar-01-23 | Downgrade | B. Riley Securities | Buy → Neutral |
| Jan-09-23 | Reiterated | B. Riley Securities | Buy |
| Dec-30-22 | Reiterated | H.C. Wainwright | Buy |
| Dec-02-22 | Initiated | Jefferies | Hold |
| Sep-22-22 | Downgrade | JP Morgan | Neutral → Underweight |
| May-20-22 | Initiated | BofA Securities | Underperform |
| Feb-23-22 | Reiterated | B. Riley Securities | Buy |
| Feb-22-22 | Resumed | Jefferies | Buy |
| Jan-21-22 | Initiated | Cowen | Outperform |
| May-12-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-14-20 | Initiated | Jefferies | Buy |
| Aug-06-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-05-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-05-20 | Downgrade | Ladenburg Thalmann | Neutral → Sell |
| Jul-16-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-08-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jun-29-20 | Reiterated | B. Riley FBR | Buy |
| Jun-29-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-05-20 | Upgrade | JP Morgan | Underweight → Neutral |
| May-28-20 | Reiterated | B. Riley FBR | Buy |
| May-12-20 | Reiterated | H.C. Wainwright | Buy |
| Apr-30-20 | Reiterated | H.C. Wainwright | Buy |
| Nov-27-19 | Resumed | B. Riley FBR | Buy |
| Aug-14-19 | Reiterated | H.C. Wainwright | Buy |
| Feb-28-19 | Downgrade | Piper Jaffray | Overweight → Underweight |
| Dec-18-18 | Initiated | Ladenburg Thalmann | Buy |
| Dec-11-18 | Initiated | Oppenheimer | Outperform |
| Nov-26-18 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Sep-21-18 | Upgrade | JP Morgan | Underweight → Overweight |
| Mar-29-18 | Upgrade | Seaport Global Securities | Neutral → Buy |
View All
Novavax Inc Stock (NVAX) Latest News
Market Voices: Kenvue vs. RFK Jr., COVID shot safety, Lendbuzz IPO - Seeking Alpha
Northern Trust Corp Sells 48,282 Shares of Novavax, Inc. $NVAX - MarketBeat
Park West Asset Management LLC Invests $16.21 Million in Novavax, Inc. $NVAX - MarketBeat
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know - sharewise.com
FDA Moves To Publicize Data On Pregnant Women's Covid Vaccine Side Effects - Benzinga
Market Trends: Is Novavax Inc. currently under institutional pressureQuarterly Risk Review & Safe Entry Point Identification - Lancaster City Council
What is Novavax Inc.’s TAM (Total Addressable Market)Market Rally & AI Optimized Trading Strategy Guides - beatles.ru
Will Novavax Inc. benefit from sector rotationMarket Sentiment Report & Daily Oversold Stock Bounce Ideas - beatles.ru
Novavax Falls on Report That FDA Wants New Covid Vaccine Trial - MSN
OMERS ADMINISTRATION Corp Acquires Shares of 199,100 Novavax, Inc. $NVAX - MarketBeat
Will Novavax Inc. stock go up in YEARGap Down & Weekly High Return Stock Opportunities - خودرو بانک
Can Novavax Inc. sustain its profitabilityInsider Selling & Real-Time Buy Zone Alerts - خودرو بانک
Bollinger Bands Show Potential Breakout in Novavax Inc.Portfolio Growth Summary & Target Return Focused Stock Picks - beatles.ru
Will Novavax Inc. benefit from AI trendsMarket Risk Analysis & Fast Gain Swing Alerts - خودرو بانک
Tools to monitor Novavax Inc. recovery probabilityJuly 2025 Analyst Calls & Community Verified Watchlist Alerts - Newser
Is Novavax Inc. stock entering bullish territory2025 Price Action Summary & Consistent Profit Focused Trading Strategies - Newser
Novavax receives milestone payment after Japan approves COVID vaccine By Investing.com - Investing.com Nigeria
How to monitor Novavax Inc. with trend dashboards2025 Investor Takeaways & Risk Managed Trade Strategies - Newser
Rafferty Asset Management LLC Lowers Holdings in Novavax, Inc. $NVAX - MarketBeat
Can momentum traders help lift Novavax Inc.Layoff News & Long-Term Growth Stock Strategies - Newser
Novavax Inc. recovery potential after sell offMarket Performance Recap & Stock Timing and Entry Methods - Newser
Is Novavax Inc. a play on infrastructure spendingJuly 2025 Snapshot & Technical Pattern Based Buy Signals - خودرو بانک
Will Novavax Inc. stock go up soonPortfolio Value Report & Reliable Price Breakout Alerts - Newser
Robert F. Kennedy Took Fire From Both Republicans And Democrats Over Vaccine Overhauls: GOP Senators Defend Trump's Operation Warp Speed - Benzinga
Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment - WV News
Can Novavax Inc. benefit from deglobalizationJuly 2025 Macro Moves & Risk Controlled Swing Alerts - خودرو بانک
Is Novavax Inc. trending in predictive chart modelsChart Signals & Community Trade Idea Sharing Platform - Newser
Transcript : Novavax, Inc. Presents at Cantor Global Healthcare Conference 2025, Sep-04-2025 10 - MarketScreener
Novavax at Cantor Global Healthcare Conference: Strategic Shift and Future Prospects - Investing.com
RFK Jr. seeks to replace CDC vaccine panel members againreport - Seeking Alpha
Novavax gets Japan nod for its COVID-19 vaccine, triggers Takeda payment - MSN
Novavax COVID-19 Vaccine Approved In Japan, Triggers Milestone Payment From Partner Takeda - Stocktwits
Novavax Receives Milestone Payment from Takeda Following COVID-19 Vaccine Approval in Japan - AInvest
Novavax Says COVID-19 Vaccine Approval in Japan Triggers Takeda Milestone Payment - MarketScreener
Novavax receives milestone payment after Japan approves COVID vaccine - Investing.com
Japan Approves Next-Gen COVID Vaccine: Novavax's Nuvaxovid Targets Omicron in World's 3rd Largest Market - Stock Titan
Florida Chooses 'Medical Freedom' As State Plans To End Vaccine Mandates, Even For Schools: Experts Warn Of 'Major Disaster' - Benzinga
What is Novavax Inc. s debt to equity ratioWeekly Market Summary & Daily Technical Stock Forecast Reports - خودرو بانک
What is the long term forecast for Novavax Inc. stockQuarterly Market Summary & Verified Momentum Stock Watchlist - خودرو بانک
Novavax : Statement on Publicly Available COVID-19 Vaccine Data - MarketScreener
Pfizer, Moderna, Novavax respond to Trump’s criticism of COVID shot success - Seeking Alpha
Is Novavax Inc. forming a reversal patternStock Surge & Safe Entry Momentum Tips - Newser
Short interest data insights for Novavax Inc.July 2025 Trends & Safe Capital Growth Tips - Newser
Novavax to Participate in the Cantor Global Healthcare Conference - MarketScreener
Novavax Inc. stock daily chart insightsWeekly Risk Summary & AI Powered Market Trend Analysis - Newser
What machine learning models say about Novavax Inc.Weekly Trend Summary & Safe Capital Growth Plans - Newser
Analyzing Novavax Inc. with multi timeframe chartsWeekly Trend Summary & Weekly Top Gainers Alerts - Newser
What to expect from Novavax Inc. in the next 30 daysCPI Data & Fast Moving Trade Plans - Newser
Leading Vaccine Developer Novavax to Share Latest Updates at Major Cantor Healthcare Conference in NYC - Stock Titan
Novavax Inc Stock (NVAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):